P A Cole - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P A Cole

Showing results (71-80 of 74) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 74 results.

Molecular Cell|July 6, 2000

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAFO D Lau, T K Kundu, R E Soccio, et al.

British Journal of Cancer|December 11, 2013

Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferationY Zhang, S Dayalan Naidu, K Samarasinghe, et al.

Oncogene|April 21, 2015

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemiaG Giotopoulos, W-I Chan, S J Horton, et al.

Molecular Metabolism|June 5, 2015

GhrelinT D Müller, R Nogueiras, M L Andermann, et al.

Pageof 8

Search research articles

Showing results (71-80 of 74) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 74 results.

Molecular Cell|July 6, 2000

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAFO D Lau, T K Kundu, R E Soccio, et al.

British Journal of Cancer|December 11, 2013

Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferationY Zhang, S Dayalan Naidu, K Samarasinghe, et al.

Oncogene|April 21, 2015

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemiaG Giotopoulos, W-I Chan, S J Horton, et al.

Molecular Metabolism|June 5, 2015

GhrelinT D Müller, R Nogueiras, M L Andermann, et al.

Pageof 8